Status:
RECRUITING
Identification and Characterisation of Sleep Disorders in a Population of Patients With Non-small Cell Lung Cancer
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Cell Lung Cancer
Sleep Disorders
Eligibility:
All Genders
18+ years
Brief Summary
This exploratory study will identify and characterise disorders frequently reported by patients as contributing to or altering their quality of life. This will enable a decision tree to be drawn up fo...
Eligibility Criteria
Inclusion
- Patient aged 18 and over.
- Being monitored and treated for non-small cell lung cancer.
- With or without ongoing cancer-specific treatment. With no neurocognitive impairment (MoCA test score ≥26/30).
- With a clinically assessed life expectancy of more than 3 months (Royal Marsden Hospital 0-1) and general health (ECOG \<2).
- Able to understand the study documents written in French
- Able to complete the study questionnaires written in French.
- Contactable by telephone throughout the study
- Affiliated to a social security scheme or entitled beneficiary
- Not opposed to taking part in the study
Exclusion
- Patient refusing to take part in the study
- With a mental illness of the psychosis type monitored and treated prior to the study
- Patient under guardianship or curatorship
- Patient under court protection
Key Trial Info
Start Date :
December 11 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 11 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06495346
Start Date
December 11 2023
End Date
June 11 2025
Last Update
July 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HUS
Strasbourg, Grand Est, France, 67117